NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









For-Robin, Inc.

For-Robin, Inc.

Private
Williamsville, New YorkHealthcare & Life Scienceshttps://for-robin.com/

Last Round

Grant

Mar 18, 2019

Total Funding Raised

$5.87M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

For-Robin, Inc. is a biotechnology company that develops immunotherapies for breast and lung cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Imaging, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

monoclonal antibodyantibody-drug conjugateADCcancer immunotherapytargeted therapybreast cancer therapytriple-negative breast cancerTNBClung cancer therapyhumanized monoclonal antibodybiologic therapeuticoncology therapeuticsdiagnostic imagingpreclinical biotechdrug discoveryThomsen-Friedenreich antigenTF-AgNCI NExT programCRADA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

For-Robin, Inc. Comparables

Compare For-Robin, Inc. with similar companies based on industry and business-model similarity.

For-Robin, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adecto Pharmaceuticals
84%
GlycoMantra
78%
Tacalyx
78%

For-Robin, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 18, 2019
GrantJul 1, 2013
GrantJul 1, 2013
GrantMay 1, 2013

For-Robin, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Monthly visitors increased 721% MoM.

  • Mar 18, 2019

    $304K grant received from NIH RADx.

For-Robin, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

For-Robin, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about For-Robin, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWilliamsville, New York
Employee Range2
Year Founded2012
Last FundingMar 18, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.